Literature DB >> 22352343

Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign.

Massimo Andreatta1, Morten Nielsen.   

Abstract

Compared with HLA-DR molecules, the specificities of HLA-DP and HLA-DQ molecules have only been studied to a limited extent. The description of the binding motifs has been mostly anecdotal and does not provide a quantitative measure of the importance of each position in the binding core and the relative weight of different amino acids at a given position. The recent publication of larger data sets of peptide-binding to DP and DQ molecules opens the possibility of using data-driven bioinformatics methods to accurately define the binding motifs of these molecules. Using the neural network-based method NNAlign, we characterized the binding specificities of five HLA-DP and six HLA-DQ among the most frequent in the human population. The identified binding motifs showed an overall concurrence with earlier studies but revealed subtle differences. The DP molecules revealed a large overlap in the pattern of amino acid preferences at core positions, with conserved hydrophobic/aromatic anchors at P1 and P6, and an additional hydrophobic anchor at P9 in some variants. These results confirm the existence of a previously hypothesized supertype encompassing the most common DP alleles. Conversely, the binding motifs for DQ molecules appear more divergent, displaying unconventional anchor positions and in some cases rather unspecific amino acid preferences.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22352343      PMCID: PMC3385030          DOI: 10.1111/j.1365-2567.2012.03579.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.

Authors:  Christian Siebold; Bjarke E Hansen; Jessica R Wyer; Karl Harlos; Robert E Esnouf; Arne Svejgaard; John I Bell; Jack L Strominger; E Yvonne Jones; Lars Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  Amino acid substitution matrices from protein blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

3.  Sequence logos: a new way to display consensus sequences.

Authors:  T D Schneider; R M Stephens
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

4.  Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.

Authors:  Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

5.  HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.

Authors:  Florence A Castelli; Cécile Buhot; Alain Sanson; Hassane Zarour; Sandra Pouvelle-Moratille; Céline Nonn; Hanne Gahery-Ségard; Jean-Gérard Guillet; André Ménez; Bertrand Georges; Bernard Maillère
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

6.  Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci.

Authors:  T L Bugawan; G T Horn; C M Long; E Mickelson; J A Hansen; G B Ferrara; G Angelini; H A Erlich
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

7.  The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.

Authors:  F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid
Journal:  Eur J Immunol       Date:  1996-11       Impact factor: 5.532

8.  Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.

Authors:  K H Lee; K W Wucherpfennig; D C Wiley
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

9.  Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding.

Authors:  Gema Díaz; Massimo Amicosante; Dolores Jaraquemada; Richard H Butler; M Victoria Guillén; Miguel Sánchez; César Nombela; Javier Arroyo
Journal:  Int Immunol       Date:  2003-05       Impact factor: 4.823

10.  NNAlign: a web-based prediction method allowing non-expert end-user discovery of sequence motifs in quantitative peptide data.

Authors:  Massimo Andreatta; Claus Schafer-Nielsen; Ole Lund; Søren Buus; Morten Nielsen
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

View more
  10 in total

1.  Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.

Authors:  Massimo Andreatta; Vanessa I Jurtz; Thomas Kaever; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

2.  Saturation scanning of ubiquitin variants reveals a common hot spot for binding to USP2 and USP21.

Authors:  Isabel Leung; Ayelet Dekel; Julia M Shifman; Sachdev S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-19       Impact factor: 11.205

3.  NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.

Authors:  Edita Karosiene; Michael Rasmussen; Thomas Blicher; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2013-07-31       Impact factor: 2.846

4.  Blocking IAg7 class II major histocompatibility complex by drug-like small molecules alleviated Sjögren's syndrome in NOD mice.

Authors:  Shivai Gupta; Danmeng Li; David A Ostrov; Cuong Q Nguyen
Journal:  Life Sci       Date:  2021-11-27       Impact factor: 5.037

5.  Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification.

Authors:  Massimo Andreatta; Edita Karosiene; Michael Rasmussen; Anette Stryhn; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2015-09-29       Impact factor: 2.846

6.  NNAlign: a platform to construct and evaluate artificial neural network models of receptor-ligand interactions.

Authors:  Morten Nielsen; Massimo Andreatta
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

Review 7.  Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies.

Authors:  Izzet Mehmet Akcay; Seyma Katrinli; Kamil Ozdil; Gizem Dinler Doganay; Levent Doganay
Journal:  World J Gastroenterol       Date:  2018-08-14       Impact factor: 5.742

8.  Trans-Allelic Model for Prediction of Peptide:MHC-II Interactions.

Authors:  Abdoelnaser M Degoot; Faraimunashe Chirove; Wilfred Ndifon
Journal:  Front Immunol       Date:  2018-06-20       Impact factor: 7.561

Review 9.  The genetic and epigenetic landscapes of the epithelium in asthma.

Authors:  Fatemeh Moheimani; Alan C-Y Hsu; Andrew T Reid; Teresa Williams; Anthony Kicic; Stephen M Stick; Philip M Hansbro; Peter A B Wark; Darryl A Knight
Journal:  Respir Res       Date:  2016-09-22

10.  Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.

Authors:  Pierre Dillard; Hakan Köksal; Solrun Melkorka Maggadottir; Anna Winge-Main; Sylvie Pollmann; Mathilde Menard; Marit Renée Myhre; Gunhild M Mælandsmo; Vivi Ann Flørenes; Gustav Gaudernack; Gunnar Kvalheim; Sébastien Wälchli; Else Marit Inderberg
Journal:  Mol Ther       Date:  2020-11-17       Impact factor: 11.454

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.